RISK OF CANCER IN PATIENTS ON INSULIN GLARGINE AND OTHER INSULIN ANALOGUES IN COMPARISON WITH THOSE ON HUMAN INSULIN: RESULTS FROM A LARGE POPULATION-BASED FOLLOW-UP STUDY

RUITER, R., VISSER, L.E., & HERK SUKEL, M.P.. (2012). RISK OF CANCER IN PATIENTS ON INSULIN GLARGINE AND OTHER INSULIN ANALOGUES IN COMPARISON WITH THOSE ON HUMAN INSULIN: RESULTS FROM A LARGE POPULATION-BASED FOLLOW-UP STUDY. DIABETOLOGIA, 55(1), 51-62. SID. https://sid.ir/paper/631706/en

RUITER R., VISSER L.E., HERK SUKEL M.P.. RISK OF CANCER IN PATIENTS ON INSULIN GLARGINE AND OTHER INSULIN ANALOGUES IN COMPARISON WITH THOSE ON HUMAN INSULIN: RESULTS FROM A LARGE POPULATION-BASED FOLLOW-UP STUDY. DIABETOLOGIA[Internet]. 2012;55(1):51-62. Available from: https://sid.ir/paper/631706/en

R. RUITER, L.E. VISSER, and M.P. HERK SUKEL, “RISK OF CANCER IN PATIENTS ON INSULIN GLARGINE AND OTHER INSULIN ANALOGUES IN COMPARISON WITH THOSE ON HUMAN INSULIN: RESULTS FROM A LARGE POPULATION-BASED FOLLOW-UP STUDY,” DIABETOLOGIA, vol. 55, no. 1, pp. 51–62, 2012, [Online]. Available: https://sid.ir/paper/631706/en